Skip to main content

Table 1 Patient characteristics of PTL

From: Incidence and prognostic factors of primary thyroid lymphoma and construction of prognostic models for post-chemotherapy and postoperative patients: a population-based study

Characteristic

No. of patients

Percentage (%)

Total

1616

100

Age at diagnosis

 Mean ± SD

64.79 ± 15.10

 

 Median (range)

66.0(5.0–98.0)

 

  < 66

779

48.2

  ≥ 66

838

51.8

Sex

 Female

1111

68.8

 Male

505

31.2

Marital status

 Married

952

58.9

 Unmarried

664

41.1

Race

 White

1445

89.4

 Black

36

2.2

 Othersa

135

8.4

Year of diagnosis

 1998–2003

469

29.0

 2004–2009

614

38.0

 2010–2015

533

33.0

Classification

 HL

17

1.1

 Aggressive B cell NHLb

968

59.9

 Indolent B cell NHLc

477

29.5

 T cell NHL

6

0.4

 NHL-NOSd

102

6.3

 Other/Unclassified

46

2.8

Lymphoma Ann Arbor Stage

 Stage I

852

52.7

 Stage II

564

34.9

 Stage III

54

3.3

 Stage IV

146

9.0

Surgery

 Performed

944

58.4

 No

672

41.6

Chemotherapy

 Performed

1074

66.5

 No

542

33.5

Radiation

 Performed

751

46.5

 No

865

53.5

  1. a American Indian/Alaskan Native or Asian/Pacific Islander.
  2. b Included DLBCL (diffuse large B cell lymphoma) and BL (Burkitt’s lymphoma).
  3. c Included FL (follicular lymphoma), CLL/SLL (chronic lymphocytic leukemia/small lymphocytic lymphoma), and MALT (mucosal-associated lymphoid tissue)
  4. d NHL-NOS (not otherwise specified)